SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-24-007323
Filing Date
2024-10-23
Accepted
2024-10-23 16:05:19
Documents
17
Period of Report
2024-10-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT sunshine_8k.htm   iXBRL 8-K 31629
2 EMPLOYMENT AGREEMENT, DATED OCTOBER 21, 2024, BETWEEN THE COMPANY AND DR. STEVE sunshine_ex1001.htm EX-10.1 57204
3 EMPLOYMENT AGREEMENT, DATED OCTOBER 21, 2024, BETWEEN THE COMPANY AND CAMILLE SE sunshine_ex1002.htm EX-10.2 48023
4 EMPLOYMENT AGREEMENT, DATED OCTOBER 21, 2024, BETWEEN THE COMPANY AND DR. ABDERR sunshine_ex1003.htm EX-10.3 45861
  Complete submission text file 0001683168-24-007323.txt   436306

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE sbfm-20241021.xsd EX-101.SCH 3553
6 XBRL DEFINITION FILE sbfm-20241021_def.xml EX-101.DEF 29992
7 XBRL LABEL FILE sbfm-20241021_lab.xml EX-101.LAB 36550
8 XBRL PRESENTATION FILE sbfm-20241021_pre.xml EX-101.PRE 27015
19 EXTRACTED XBRL INSTANCE DOCUMENT sunshine_8k_htm.xml XML 5522
Mailing Address 333 LAS OLAS WAY CU4 SUITE 433 FORT LAUDERDALE FL 33301
Business Address 333 LAS OLAS WAY CU4 SUITE 433 FORT LAUDERDALE FL 33301 954-515-0810
Sunshine Biopharma Inc. (Filer) CIK: 0001402328 (see all company filings)

IRS No.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41282 | Film No.: 241389252
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)